DOI QR코드

DOI QR Code

Complications of transcatheter closure of atrial septal defects using the amplatzer septal occluder

심방 중격 결손의 경피적 폐쇄술 후 발생한 합병증에 관한 연구

  • Jea, Seo Jin (Departments of Pediatrics, College of Medicine, Korea University) ;
  • Kwon, Hyo Jin (Departments of Pediatrics, College of Medicine, Korea University) ;
  • Jang, Gi Young (Departments of Pediatrics, College of Medicine, Korea University) ;
  • Lee, Jae Young (Departments of Pediatric Cardiology, Sejong Heart Institute, Sejong General Hospital) ;
  • Kim, Soo Jin (Departments of Pediatric Cardiology, Sejong Heart Institute, Sejong General Hospital) ;
  • Son, Chang Sung (Departments of Pediatrics, College of Medicine, Korea University) ;
  • Lee, Joo Won (Departments of Pediatrics, College of Medicine, Korea University)
  • 제서진 (고려대학교 의과대학 소아과학교실) ;
  • 권효진 (고려대학교 의과대학 소아과학교실) ;
  • 장기영 (고려대학교 의과대학 소아과학교실) ;
  • 이재영 (부천세종병원 소아과) ;
  • 김수진 (부천세종병원 소아과) ;
  • 손창성 (고려대학교 의과대학 소아과학교실) ;
  • 이주원 (고려대학교 의과대학 소아과학교실)
  • Received : 2007.07.03
  • Accepted : 2007.11.22
  • Published : 2008.04.15

Abstract

Purpose : Transcatheter closure of atrial septal defects (ASD) is currently established therapy as an alternative to surgery. But rarely, complications are reported in some studies. We report early and intermediate term complications associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder (ASO). Methods : From June 2003 to May 2006, 64 patients underwent transcatheter closure of secundum ASD or patent foramen ovale using the ASO. The ratio of male to female was 1:2.4, the median age was 17 years (range: 2.6-64 years) and their median weight was 47.5 kg (range: 2.6-64 kg). Results : The median diameter of ASD measured with transthoracic or transesophageal echocardiography was 15 mm (range: 6-28 mm), the median balloon stretched diameter was 18 mm (range: 6.5-34 mm), and the median size of device was 19.5 mm (range: 6-36 mm), was little difference with balloon stretched diameter. There were 10 cases of complications: arrhythmia (2), device malformation (2), aorta to right atrial fistula (1), hemolytic anemia (1), mitral valve encroachment (1), malposition (1), residual shunt (1), and inferior vena cava perforation (1). Conclusion : Transcatheter closure of ASD using ASO is effective and safe therapy. However, significant complications such as aorta to atrial fistula, atrial erosion, or device embolization can happen, so an appropriate selection of patient and device in relevance to size and anatomy of ASD is important for successful closure.

목 적 : 이차공 심방 중격 결손의 경피적 폐쇄술은 수술을 대체할 수 있어 안전하고 효과적인 치료로서 자리를 잡아가고 있으나, 드물게 합병증의 발생이 보고되고 있어, Amplatzer septal occluder를 이용한 심방 중격 결손의 경피적 폐쇄술 후 발생한 초․중기 합병증 및 그 대책을 살펴보고자 하였다. 방 법 : 2003년 6월부터 2006년 5월까지 부천세종병원과 고려대학교 의료원에서 이차공 심방 중격 결손을 진단 받은 64명의 환자를 대상으로 하였다. 남녀 비는 1:2.4였고, 시술 당시 나이는 2.6에서 64세(중앙값 : 17세), 시술 당시 체중은 13 kg에서 100 kg (중앙값 : 47.5 kg)이었다. 결 과 : 경흉부 또는 경식도 심장 초음파 검사상 결손의 크기는 6 mm에서 28 mm (중앙값 : 15 mm), 풍선 확장 시 결손의 크기는 6.5 mm에서 34 mm (중앙값 : 18 mm)이었고, 사용한 Amplatzer septal occluder의 크기는 6 mm에서 36 mm (중앙값 : 19.5 mm)로 풍선 확장 시 결손의 크기와 같거나 1-2 mm 큰 크기의 기구가 사용되었다. 시술 후 발생한 합병증으로는 부정맥(2례), 기구 변형(2례), 대동맥 우심방 간 누공 형성 및 용혈성 빈혈(1례), 승모판 잠식(1례), 기구 위치 이상(1례), 잔류 단락(1례), 하대 정맥 천공(1례) 등이 있었다. 결 론 : ASO를 이용한 심방 중격 결손의 경피적 폐쇄술은 안전성이나 효과, 기술적인 면에서 수술을 대체할 수 있는 효율적인 치료로 생각된다. 그러나 드물게 발생하는 기구 이탈이나 부정맥, 심장막 삼출, 누공 형성 등의 합병증이 발생할 수 있으므로 시술 전 주의 깊게 대상 환자를 선정하고, 심방 중격 결손의 정확한 해부학적 이해와 기구 선택이 필요하며 시술 후 추적 관찰을 통해 합병증의 조기 발견 및 예방이 필요할 것으로 판단된다.

Keywords

References

  1. Tikkanen J, Heinonen OP. Risk factors for atrial septal defect. Eur J Epidemiol 1992;8:509-15 https://doi.org/10.1007/BF00146368
  2. Thilen UJ. Closure of atrial septal defect: is the debate over? Eur Heart J 2003;24:1797; author reply-8
  3. Spence MS, Qureshi SA. Complications of transcatheter closure of atrial septal defects. Heart 2005;91:1512-4 https://doi.org/10.1136/hrt.2004.057562
  4. King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 1976;235:2506-9 https://doi.org/10.1001/jama.235.23.2506
  5. Lock JE, Rome JJ, Davis R, Van Praagh S, Perry SB, Van Praagh R, et al. Transcatheter closure of atrial septal defects. Experimental studies. Circulation 1989;79:1091-9 https://doi.org/10.1161/01.CIR.79.5.1091
  6. Knirsch W, Dodge-Khatami A, Balmer C, Peuster M, Kadner A, Weiss M, et al. Aortic sinus-left atrial fistula after interventional closure of atrial septal defect. Catheter Cardiovasc Interv 2005;66:10-3 https://doi.org/10.1002/ccd.20436
  7. Rao PS, Wilson AD, Levy JM, Gupta VK, Chopra PS. Role of 'buttoned' double-disc device in the management of atrial septal defects. Am Heart J 1992;123:191-200 https://doi.org/10.1016/0002-8703(92)90765-N
  8. Kaulitz R, Paul T, Hausdorf G. Extending the limits of transcatheter closure of atrial septal defects with the double umbrella device (CardioSEAL). Heart 1998;80:54-9
  9. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004;63:496-502 https://doi.org/10.1002/ccd.20211
  10. Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart 2003;89:199-204 https://doi.org/10.1136/heart.89.2.199
  11. Demkow M, Ruzyllo W, Konka M, Kepka C, Kowalski M, Wilczynski J, et al. Transvenous closure of moderate and large secundum atrial septal defects in adults using the Amplatzer septal occluder. Catheter Cardiovasc Interv 2001; 52:188-93 https://doi.org/10.1002/1522-726X(200102)52:2<188::AID-CCD1045>3.0.CO;2-6
  12. Hughes ML, Maskell G, Goh TH, Wilkinson JL. Prospective comparison of costs and short term health outcomes of surgical versus device closure of atrial septal defect in children. Heart 2002;88:67-70 https://doi.org/10.1136/heart.88.1.67
  13. Masura J. Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Catheterization and cardiovascular diagnosis 1997;42:388-93 https://doi.org/10.1002/(SICI)1097-0304(199712)42:4<388::AID-CCD7>3.0.CO;2-7
  14. BialkowskiJ, Karwot B, Szkutnik M, Banaszak P, Kusa J. Skalski J Closure of atrial septal defects in children: surgery versus Amplatzer device implantation. Tex Heart Inst J 2004;31:220-3
  15. Harper RW, Mottram PM, McGaw DJ Closure of secundum atrial septal defects with the Amplatzer septal occluder device: techniques and problems. Catheter Cardiovasc Interv 2002;57:508-24 https://doi.org/10.1002/ccd.10353
  16. Hijazi ZM. Catheter closure of atrial septal and ventricular septal defects using the Amplatzer devices. Heart Lung Circ 2003;12 Suppl 2:63-72 https://doi.org/10.1046/j.1443-9506.2003.t01-3-.x
  17. Durongpisitkul K, Soongswang J. Laohaprasitiporn D, Nana A, Sriyoschati S, Ponvilawan S, et al. Comparison of atrial septal defect closure using amplatzer septal occluder with surgery. Pediatr Cardiol 2002;23:36-40 https://doi.org/10.1007/s00246-001-0010-6
  18. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 2002;39:1836-44 https://doi.org/10.1016/S0735-1097(02)01862-4
  19. Butera G, Lucente M, Rosti L, Chessa M, Micheletti A, Giamberti A, et al. A comparison between the early and mid-term results of surgical as opposed to percutaneous closure of defects in the oval fossa in children aged less than 6 years. Cardiol Young 2007;17:35-41 https://doi.org/10.1017/S104795110600134X
  20. Masura J, Gavora P, Podnar T. Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am Coll Cardiol 2005; 45:505-7 https://doi.org/10.1016/j.jacc.2004.10.066
  21. Butera G, Carminati M, Chessa M, Youssef R, Drago M, Giamberti A, et al. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am Heart J 2006;151:228-34 https://doi.org/10.1016/j.ahj.2005.02.051
  22. Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39:1061-5 https://doi.org/10.1016/S0735-1097(02)01711-4
  23. Waight DJ, Koenig PR, Cao QL, Hijazi ZM. Transcatheter Closure of Secundum Atrial Septal Defects Using the Amplatzer Septal Occluder Clinical Experience and Technical Considerations. Curr Interv Cardiol Rep 2000;2:70-7
  24. Mashman WE, King SB, Jacobs WC, Ballard WL. Two cases of late embolization of Amplatzer septal occluder devices to the pulmonary artery following closure of secundum atrial septal defects. Catheter Cardiovasc Interv 2005;65:588-92 https://doi.org/10.1002/ccd.20429
  25. Hill SL, Berul CI, Patel HT, RhodesJ, Supran SE, Cao QL, et al. Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder. J Interv Card Electrophysiol 2000;4:469-74 https://doi.org/10.1023/A:1009852312907
  26. Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 1999;340:839-46 https://doi.org/10.1056/NEJM199903183401103
  27. Mello DM, FaheyJ, Kopf GS. Repair of aortic-left atrial fistula following the transcatheter closure of an atrial septal defect. Ann Thorac Surg 2005;80:1495-8 https://doi.org/10.1016/j.athoracsur.2004.03.098
  28. Mahadevan VS, Horlick EM, Benson LN, McLaughlin PR. Transcatheter closure of aortic sinus to left atrial fistula caused by erosion of amplatzer septal occluder. Catheter Cardiovasc Interv 2006;68:749-53 https://doi.org/10.1002/ccd.20900
  29. Grifka RG, O'Laughlin MP, Mullins CE. Late transcatheter removal of a Rashkind PDA occlusion device for persistent hemolysis using a modified trans septal sheath. Catheterization and cardiovascular diagnosis 1992;25:140-3 https://doi.org/10.1002/ccd.1810250210
  30. Mazic U, Gavora P, Masura J. 'Cobra-like' deformation of an Amplatzer septal occluder. Pediatr Cardiol 2001;22:253-4 https://doi.org/10.1007/s002460010216
  31. Cooke JC, Gelman JS, Harper RW. Cobrahead malformation of the Amplatzer septal occluder device: an avoidable com- pilation of percutaneous ASD closure. Catheter Cardiovasc Interv 2001;52:83-5 https://doi.org/10.1002/1522-726X(200101)52:1<83::AID-CCD1020>3.0.CO;2-#
  32. Shaw JA, Dewire E, Nugent A, Eisenhauer AC. Use of suture-mediated vascular closure devices for the mana gement of femoral vein access after transcatheter procedures. Catheter Cardiovasc Interv 2004;63:439-43 https://doi.org/10.1002/ccd.20190
  33. Wiley JM, White CJ, Uretsky BF. Noncoronary complications of coronary intervention. Catheter Cardiovasc Interv 2002;57:257-65 https://doi.org/10.1002/ccd.10307
  34. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004:43:302-9 https://doi.org/10.1016/j.jacc.2003.10.030
  35. Anzai H, Child J, Natterson B, Krivokapich J, Fishbein MC, Chan VK, et al. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol 2004;93:426-31 https://doi.org/10.1016/j.amjcard.2003.10.036
  36. Wang JK, Tsai SK, Wu MH, Lin MT, Lue HC. Short- and intermediate-term results of transcatheter closure of atrial septal defect with the Amplatzer Septal Occluder. Am Heart J 2004;148:511-7 https://doi.org/10.1016/j.ahj.2004.01.030

Cited by

  1. 3세 미만 심방중격결손 소아에서 Amplatzer 기구 폐쇄술의 안전성 및 효용성 vol.52, pp.4, 2009, https://doi.org/10.3345/kjp.2009.52.4.494